propranolol has been researched along with Neonatal Abstinence Syndrome in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report three infants with infantile hemangioma who experienced severe agitation and diarrhea following propranolol administration." | 8.12 | Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects. ( Chen, A; Poffenberger, P; Twist, J; Zinn, Z, 2022) |
| "We report three infants with infantile hemangioma who experienced severe agitation and diarrhea following propranolol administration." | 4.12 | Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects. ( Chen, A; Poffenberger, P; Twist, J; Zinn, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Twist, J | 1 |
| Chen, A | 1 |
| Poffenberger, P | 1 |
| Zinn, Z | 1 |
1 other study available for propranolol and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects.
Topics: Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Iatrogenic Disease; Infant; | 2022 |